January 12, 2026

Danaher Corporation (DHR) Stock Analysis: Healthcare Giant’s 9.51% Upside and Strong Buy Consensus

Danaher Corporation (NYSE: DHR) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $170.69..

Astrazeneca PLC (AZN)

⚠️ No article content returned.

..

DexCom, Inc. (DXCM) Investor Outlook: 26.63% Potential Upside and Strong Buy Ratings

DexCom, Inc. (DXCM), a frontrunner in the healthcare sector specializing in medical devices, is gaining attention among investors with its robust growth trajectory and significant market..

Genmab A/S (GMAB) Stock Analysis: Unpacking the 10.37% Upside Potential for Biotech Investors

As one of the standout players in the biotechnology sector, Genmab A/S (GMAB) continues to capture the attention of investors with its promising product pipeline and..

ResMed Inc. (RMD) Stock Analysis: Exploring a 15.58% Upside Potential Amid Robust Healthcare Innovations

ResMed Inc. (NYSE: RMD) stands as a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a sizable market capitalization..

Quest Diagnostics (DGX) Stock Analysis: Promising 13.54% Upside Potential for Healthcare Investors

Quest Diagnostics Incorporated (NYSE: DGX), a key player in the healthcare sector under the diagnostics and research industry, stands out with its formidable $19.51 billion market..

Thermo Fisher Scientific Inc (TMO): Investor Outlook on Its 5% Potential Upside and Robust Analyst Ratings

For investors eyeing the healthcare sector, Thermo Fisher Scientific Inc (NYSE: TMO) offers a compelling mix of growth potential and stability. As a leader in the..

Tenet Healthcare Corporation (THC) Stock Analysis: An Investor’s Insight into Its 17.53% Potential Upside

Tenet Healthcare Corporation (NYSE: THC), a notable player in the healthcare sector, presents a compelling case for investors interested in the medical care facilities industry. With..

The Cooper Companies, Inc. (COO) Stock Analysis: Healthcare Leader Eyes 9% Upside Potential

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the medical instruments and supplies industry, is garnering attention from investors due to its steady performance..

Incyte Corporation (INCY) Stock Analysis: Strong Revenue Growth and Strategic Developments in the Biotech Sector

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology industry, continues to capture the attention of investors with its robust pipeline of therapeutics and impressive..

Gilead Sciences, Inc. (GILD) Stock Analysis: Strong Buy Ratings and 10.84% Potential Upside

Gilead Sciences, Inc. (NASDAQ: GILD), a prominent player in the healthcare sector, particularly within the drug manufacturing industry, has been a focal point for investors seeking..

Summit Therapeutics Inc. (SMMT): Investor Outlook on a Biotech Stock with 66.79% Upside Potential

Summit Therapeutics Inc. (NASDAQ: SMMT) stands out in the biotech sector with its focus on pioneering medicinal therapies, including its lead candidate, ivonescimab, which is in..

IQVIA Holdings, Inc. (IQV): Investor Outlook Reveals 6.22% Potential Upside with Strong Buy Ratings

IQVIA Holdings, Inc. (IQV), a prominent player in the healthcare sector, continues to capture investor attention with its robust market presence and promising growth prospects. As..

Zoetis Inc. (ZTS) Stock Analysis: Exploring 24.41% Potential Upside with Strong Buy Ratings

Zoetis Inc. (NYSE: ZTS), a leader in animal health, has been making headlines in the healthcare sector with its solid market presence and consistent product innovation...

Teva Pharmaceutical Industries (TEVA) Stock Analysis: A Promising 10% Upside Potential

Teva Pharmaceutical Industries (NYSE: TEVA), a prominent player in the healthcare sector, commands attention from investors with its substantial market capitalization of $36.72 billion and a..

Cardinal Health (CAH) Stock Analysis: A Leading Healthcare Distributor with a 10.49% Upside Potential

Cardinal Health, Inc. (NYSE: CAH), a stalwart in the healthcare services and medical distribution sector, stands as a prominent player with a substantial market capitalization of..

Stryker Corporation (SYK) Stock Analysis: Exploring a 16% Upside Potential with Strong Buy Ratings

Stryker Corporation (NYSE: SYK), a leading player in the medical devices industry, is capturing investor attention with its robust market performance and promising growth outlook. Headquartered..

STERIS plc (Ireland) (STE)

⚠️ No article content returned.

..

Smith & Nephew (SNN) Stock Analysis: Exploring a 9.12% Potential Upside in the Medical Devices Sector

Smith & Nephew SNATS, Inc. (SNN) stands as a formidable player in the healthcare sector, specifically within the medical devices industry. Based in the United Kingdom,..

Baxter International Inc. (BAX) Stock Analysis: Evaluating Growth Potential Amidst a 10.43% Upside

Baxter International Inc. (NYSE: BAX) stands as a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization..

Search

Funds

January 12, 2026

Search

Funds

January 12, 2026

FTSE 100

Funds